Premium
Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase‐1) in osteoarthritic chondrocytes
Author(s) -
Takizawa Masayuki,
Yatabe Taku,
Okada Aiko,
Chijiiwa Miyuki,
Mochizuki Satsuki,
Ghosh Peter,
Okada Yasunori
Publication year - 2008
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2008.07.036
Subject(s) - aggrecanase , adamts , aggrecan , chemistry , osteoarthritis , calcium , microbiology and biotechnology , matrix metalloproteinase , thrombospondin , metalloproteinase , pharmacology , biochemistry , medicine , articular cartilage , biology , pathology , alternative medicine , organic chemistry
Aggrecanases that include ADAMTS1, 4, 5, 8, 9 and 15 are considered to play key roles in aggrecan degradation in osteoarthritic cartilage. Here we demonstrate that calcium pentosan polysulfate (CaPPS) directly inhibits the aggrecanase activity of ADAMTS4 without affecting the mRNA expression of the ADAMTS species in interleukin‐1α‐stimulated osteoarthritic chondrocytes. Synthetic peptides corresponding to specific regions of the thrombospondin type 1 repeat, cysteine‐rich or spacer domain of ADAMTS4 inhibit the binding to immobilized CaPPS. These data suggest that CaPPS could function as chondroprotective agent for the treatment of osteoarthritis by inhibition of ADAMTS4 through interaction with the C‐terminal ancillary domain.